Precision AQ
Greg Gregory, PhDExecutive Vice President, Partner
Greg Gregory is a market access and commercialization strategist who partners with biopharmaceutical companies to translate scientific innovation into real-world patient access. He focuses on pricing, reimbursement, and broader commercialization strategy across oncology and other complex specialty therapeutics, and is known for developing defendable, evidence-based approaches that align clinical value with real-world market dynamics. His work connects payer, provider, and patient considerations to support high-stakes decisions across development, launch, and lifecycle management. Drawing on a background in immunology and postdoctoral training in hematology, he brings a strong scientific foundation to designing commercialization strategies that resonate with both clinical and market stakeholders.
Insights from Greg Gregory, PhD
Commercialization & Access | White Paper
How Health Systems Are Using AI In Clinical Decision-Making
Research & Development | White Paper
Breaking Through in Hematologic Malignancies
Commercialization & Access | Industry Brief
Twenty-Five Years of Antibody–Drug Conjugates: From Breakthroughs to Access by Design
Commercialization & Access | White Paper
Challenges and Opportunities for Radiopharmaceutical Commercialization